A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma-Reference-Cited by-同舟云学术

A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma

Published:2017-11-06 Issue:62 Volume:8 Page:105492-105509
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shoshan-Barmatz Varda¹,Bishitz Yael¹,Paul Avijit¹,Krelin Yakov¹,Nakdimon Itay¹,Peled Nir²,Lavon Avia¹,Rudoy-Zilberman Elina³,Refaely Yael³

Affiliation:

1. Department of Life Sciences and The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel

2. Thoracic Cancer Unit and The Center for Precision Cancer Care, Davidoff Cancer Center, Petach Tiqwa, Israel

3. Department of Cardio-Thoracic Surgery, Soroka University Medical Center and The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the secretome of EGFR mutant lung adenocarcinoma;Frontiers in Oncology;2024-01-08

2. AI-Assisted Digital Pathology for Computational distinction of adenocarcinoma vs squamous cell carcinoma;2023 29th International Conference on Mechatronics and Machine Vision in Practice (M2VIP);2023-11-21

3. Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study;Scientific Reports;2023-04-17

4. Integrated spatial analysis of gene mutation and gene expression for understanding tumor diversity in formalin-fixed paraffin-embedded lung adenocarcinoma;Frontiers in Oncology;2022-11-24

5. Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancer;Cancer Medicine;2022-06-08